A woman has filed an abdominal mesh lawsuit against the manufacturers of the C-Qur Mesh, Atrium Medical Corporation, alleging she suffered severe internal adverse side effects and complications because of the product’s implantation.

Plaintiff Christine G. files the abdominal mesh lawsuit in New Hampshire federal court joining an increasing multidistrict litigation (MDL) against the company.

According to the abdominal mesh lawsuit, Christine, a resident of the state of Alabama, says that she was implanted with the C-Qur mesh on Feb. 11, 2014 at the University of South Alabama. However, it was on July 28, 2014 that she had the product implant explanted due to adverse side effects she suffered, the abdominal mesh lawsuit states.

Adverse effects she suffered include chronic infection because of the multiple surgeries she endured to remove the infected tissue. She also says she suffered from chronic pain, sinus tracts, and seroma.

The abdominal mesh lawsuit was filed on multiple counts including negligence, design defect, manufacturing defect, failure to warn, defective product, breach of express warranty, breach of implied warranty, fraudulent concealment, constructive fraud, among others.

Christine demands a trial by jury.

Overview: Atrium C-Qur Hernia Mesh

Christine’s claim is filed as part of an MDL centered on allegations that the Atrium C-Qur hernia mesh causes severe internal adverse side effects and complications.

The body’s rejection of the C-Qur mesh has resulted in severe complications and adverse effects for patients. As the body is unable to accept the hernia mesh, it responds with a severe allergic reaction. The rejection is said to be the result of the Omega 3 fatty oil coating.

Following rejection of the hernia mesh, patients have seen discoloration, swelling, and tenderness surrounding the area of the implant.

According to the U.S. Food and Drug Administration (FDA), following hernia mesh implantation, complications that have been reported include “pain, infection, hernia recurrence, adhesion, and bowel obstruction.”

“Some other potential adverse events that can occur following hernia repair with mesh are mesh migration and mesh shrinkage (contraction).”

The adverse effects and complications that specifically result from the implantation of a C-Qur mesh have been blamed on the product’s Omega 3 gel coating. Although the Omega 3 coating was manufactured with the hopes of reducing the likelihood of the mesh attaching to the body’s internal tissues, studies have shown that the Omega 3 coating offers no additional health benefit.

Purportedly because of the fatty acid gel, patients have suffered from an increasing range of patient infection, concluding the mesh unsuitable for implantation in the human body.

In July 2013, the FDA announced a Class 2 Device Recall of the C-Qur Edge mesh because of unsurmountable adverse effects the device caused. However, although the device was recalled, there are still people suffering from life-threatening side effects and severe injuries.

The Abdominal Mesh Lawsuit is Case No. 1:18-cv-00069, in the U.S. District Court for the District of New Hampshire. The Hernia Mesh MDL is In re: Atrium Medical Corp., C-Qur Mesh Products Liability Litigation, MDL No 2753, in the U.S. District Court for the District of New Hampshire.